Dr Mike Kenny is the Business Development Manager at AM Technology, who manufacture the Coflore range of continuous flow reactors.
Dr Kenny graduated with a PhD degree from the University of Bath in 2018, having worked on the synthesis of highly cytotoxic cyclopropabenzindoles, as part of a project funded by Prostate Cancer UK under the supervision of Prof. Michael D. Threadgill. Today, Dr Kenny works with the chemical industry to both bring new chemical processes, and convert existing batch processes, into continuous manufacture.